Summit Therapeutics (NASDAQ:SMMT) Showcases Promising Data at J.P. Morgan Healthcare Conference
Summit Therapeutics recently presented their latest developments at the 43rd Annual J.P. Morgan Healthcare Conference. The event featured discussions led by Bob Duggan, the Chairman & CEO, and Dr. Maky Zanganeh, the CEO & President. During the presentation, Summit Therapeutics outlined their future expectations and strategic plans surrounding the clinical and preclinical development of their […]
More Stories
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) To Go Ex-Dividend on January 14th
Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE:FOF – Get Free Report) announced a dividend on Monday, January 13th,investing.com reports....
InnSuites Hospitality Trust (IHT) To Go Ex-Dividend on January 24th
InnSuites Hospitality Trust (NYSE:IHT – Get Free Report) declared a semi-annual dividend on Monday, January 13th,Wall Street Journal reports. Investors...
Neuberger Berman Real Estate Securities Income Fund Inc. (NYSEAMERICAN:NRO) Announces $0.03 Monthly Dividend
Neuberger Berman Real Estate Securities Income Fund Inc. (NYSEAMERICAN:NRO – Get Free Report) announced a monthly dividend on Monday, January...
Aberdeen Total Dynamic Dividend Fund (AOD) To Go Ex-Dividend on January 24th
Aberdeen Total Dynamic Dividend Fund (NYSE:AOD – Get Free Report) declared a monthly dividend on Monday, January 13th,Wall Street Journal...
Option Care Health (NASDAQ:OPCH) Issues FY25 Earnings Guidance
Option Care Health (NASDAQ:OPCH – Get Free Report) updated its FY25 earnings guidance on Monday morning. The company provided earnings...
Flowers Foods (NYSE:FLO) Sets New 52-Week Low – Here’s Why
Flowers Foods, Inc. (NYSE:FLO – Get Free Report)’s stock price reached a new 52-week low during trading on Monday ....